Stephens & Co. Maintains Overweight on Braze, Raises Price Target to $34

Benzinga Newsdesk www.benzinga.com Positive 75.1%

Neg 0% Neu 0% Pos 75.1%

Stephens & Co. analyst Brett Huff maintains Braze (NASDAQ:BRZE) with a Overweight and raises the price target from $31 to $34.